Himalaya Therapeutics Announces Highlights of Recent Clinical Progress
/PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of...
Stay updated with breaking news from Soft Tissue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of...
Sorry, but your browser does not support the video tag.
Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a clinical-stage biotechnology company developing novel immunotherapies for cancer and autoimmune disease, today provides an update on the ongoing development of its product candidates, eftilagimod alpha ("efti") and IMP761 for the quarter ended ...
In species such as horses, pharmaceutical and surgical interventions carry risks and are not always as effective as hoped, but the rapid evolution of medical technology is enabling dramatic improvements in what treatments and diagnostic tools are available.
Calvin got diagnosed june 10 of 2018. he has rhabdomyosarcoma, a soft tissue cancer. but st. jude has covered everything. and coming here, they're like, we are going to do everything we can. and when they say everything, they mean everything. st. jude is the gold at the end of a rainbow for a family like ours. they've really given our family hope. and we are so grateful and thankful for everything.